CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
87 hedge funds and large institutions have $1.29B invested in China Biologic Products Holdings, Inc. in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
-1
Holders Change %
-1.14%
% of All Funds
1.72%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
13
Increased
29
Reduced
31
Closed
14
Calls
$30.4M
Puts
$13.2M
Net Calls
+$17.2M
Net Calls Change
+$26.7M
Top Buyers
| 1 |
MCP
Maso Capital Partners
Hong Kong
|
+$36.8M |
| 2 |
KLCMU
Kite Lake Capital Management (UK)
London,
United Kingdom
|
+$24.1M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$16.3M |
| 4 |
Man Group
London,
United Kingdom
|
+$10.5M |
| 5 |
Goldman Sachs
New York
|
+$8.42M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$4K | -36 | Closed |
|